» Articles » PMID: 35848564

Utilization of Nasal Mucus to Investigate the Pathophysiology of Chronic Rhinosinusitis

Overview
Publisher Sage Publications
Date 2022 Jul 18
PMID 35848564
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nasal mucus is proving to be a useful means by which to study the pathogenesis of chronic rhinosinusitis (CRS). Given the increase in publications examining nasal mucus and the lack of a review on this topic, we will focus on this noninvasive approach to studying CRS. Particular attention will be drawn towards inflammatory cytokines and biomarkers and their influence on disease severity.

Methods: A literature review of papers published in English pertaining to nasal mucus was performed using the PubMed database. The search utilized combinations of the following keywords: sinusitis, polyps, sample collection, nasal mucus, or nasal secretion. Studies solely on acute or bacterial sinusitis, allergic rhinitis, or cystic fibrosis were not included.

Results: A wide variety of materials and methods have been used to collect nasal mucus. Numerous assay types have been performed with the most common being ELISA, cytometric bead array, and proteomics. Most studies have focused on examining the levels of Th1/Th2 cytokines along with chemokines associated with type 2 immunity. Other factors identified include growth factors, senescence-associated proteins, complement, and antimicrobial defenses have also been identified. Nasal mucus cytokines have proven useful in cluster analysis and predicting postoperative improvement in Sino-nasal Outcome Test (SNOT-22) scores. One limitation of the use of nasal mucus is that some studies have suggested that nasal mucus does not always reflect the tissue microenvironment.

Conclusions: Nasal mucus represents a critical tool by which to examine the sinonasal microenvironment in a noninvasive manner. Unlike studies of tissue, it can be utilized in both surgically and medically managed patients and avoids the trauma of biopsies. However, studies are still needed to determine the most effective method for nasal mucus collection. Studies should also take care to confirm that nasal mucus markers do, in fact, reflect the levels of the product studied in the tissue.

Citing Articles

Serum Periostin as a Potential Biomarker in the Evaluation of Allergic Rhinitis: A Pilot Study.

Zhu X, Lu M, Chen R, Mao Z, Yang Y, Han J J Asthma Allergy. 2025; 18():1-12.

PMID: 39801732 PMC: 11721334. DOI: 10.2147/JAA.S496020.


Assessing the predictive potential of ADAM8 for disease control in chronic rhinosinusitis with nasal polyps.

Liu P, Liu M, Sun Y, Lei W, Xu Y Front Allergy. 2024; 5:1488441.

PMID: 39588470 PMC: 11586353. DOI: 10.3389/falgy.2024.1488441.


Recent advances in mass spectrometry-based proteomics and metabolomics in chronic rhinosinusitis with nasal polyps.

Guo S, Tian M, Fan Y, Zhang X Front Immunol. 2023; 14:1267194.

PMID: 37744372 PMC: 10511644. DOI: 10.3389/fimmu.2023.1267194.


All chronic rhinosinusitis endotype clusters demonstrate improvement in patient-reported and clinical outcome measures after endoscopic sinus surgery.

Chapurin N, Schlosser R, Gutierrez J, Mace J, Smith T, Bodner T Int Forum Allergy Rhinol. 2023; 14(4):765-774.

PMID: 37563836 PMC: 10858289. DOI: 10.1002/alr.23255.


The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids.

Bartosik T, Campion N, Freisl K, Liu D, Gangl K, Stanek V Front Immunol. 2023; 14:1112345.

PMID: 37122714 PMC: 10140405. DOI: 10.3389/fimmu.2023.1112345.